We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,245 hedge funds and large institutions have $56.9B invested in Celgene Corp in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 350 increasing their positions, 572 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 109127 (+18)

12% more capital invested

Capital invested by funds: $51.1B → $56.9B (+$5.88B)

3% less funds holding

Funds holding: 1,2871,245 (-42)

31% less first-time investments, than exits

New positions opened: 73 | Existing positions closed: 106

39% less repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 572

59% less call options, than puts

Call options by funds: $796M | Put options by funds: $1.95B

Holders
1,245
Holders Change
-42
Holders Change %
-3.26%
% of All Funds
27.3%
Holding in Top 10
127
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+16.51%
% of All Funds
2.79%
New
73
Increased
350
Reduced
572
Closed
106
Calls
$796M
Puts
$1.95B
Net Calls
-$1.15B
Net Calls Change
-$98.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
201
Wellington Management Group
Massachusetts
$28.2M +$9.04M +95,151 +50%
Royal London Asset Management
202
Royal London Asset Management
United Kingdom
$27.4M -$506K -5,323 -2%
NC
203
Nicholas Company
Wisconsin
$27.3M
ACI
204
AMP Capital Investors
Australia
$26.9M -$1.2M -12,640 -4%
ZDA
205
Zweig-DiMenna Associates
New York
$26.8M -$16.8K -177 -0.1%
OPERF
206
Oregon Public Employees Retirement Fund
Oregon
$26.8M -$396K -4,171 -2%
BNP Paribas Asset Management
207
BNP Paribas Asset Management
France
$26.8M -$26.1M -274,285 -50%
QIM
208
Quantitative Investment Management
Virginia
$26.1M +$24.9M +262,429 New
RJA
209
Raymond James & Associates
Florida
$25.9M -$1.94M -20,438 -7%
CCM
210
Chicago Capital Management
Illinois
$25.8M +$5.7M +60,000 +30%
RFC
211
Regions Financial Corp
Alabama
$25.8M -$471K -4,955 -14%
Calamos Advisors
212
Calamos Advisors
Illinois
$25.4M +$1.85M +19,454 +8%
William Blair & Company
213
William Blair & Company
Illinois
$25M -$1.24M -13,071 -5%
Aviva
214
Aviva
United Kingdom
$25M -$1.15M -12,057 -5%
SFM
215
Sphera Funds Management
Israel
$24.8M
SM
216
Selkirk Management
New Jersey
$24.7M
LSV Asset Management
217
LSV Asset Management
Illinois
$24.5M
BIM
218
Bridges Investment Management
Nebraska
$24.3M -$11M -115,454 -32%
VOAM
219
Vertex One Asset Management
British Columbia, Canada
$23.6M +$2.28M +24,000 +11%
TD Asset Management
220
TD Asset Management
Ontario, Canada
$23.2M -$1.08M -11,320 -5%
QOP
221
Quinn Opportunity Partners
Virginia
$22.4M +$11.4M +120,000 +113%
Nomura Asset Management
222
Nomura Asset Management
Japan
$22.4M -$3.35M -35,300 -14%
AC
223
Athos Capital
Hong Kong
$22M +$3.2M +33,633 +18%
LOAMU
224
Lombard Odier Asset Management (USA)
New York
$21.8M +$3.8M +40,000 +22%
GI
225
GAMCO Investors
Connecticut
$21.8M -$1.37M -14,400 -6%

CELG Hedge Fund Activity: Q3 2019 in Review

1,245 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2019, worth a combined $56.9B — up 12% from $51.1B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of CELG and 73 opened new positions — a net loss of 33 holders — while 572 trimmed existing stakes and 350 added.

The largest buyer was HBK Investments, opening a new position worth an estimated $1.5B. The largest seller was Fidelity Investments, cutting an estimated $377M.

  • 1,245 institutional investors held Celgene Corp (CELG) as of Q3 2019, down from 1,287 in Q2 2019.
  • Funds reported $56.9B of Celgene Corp stock for Q3 2019, up 12% quarter-over-quarter.
  • 73 funds opened new Celgene Corp positions in Q3 2019 and 106 closed out, a net change of -33 holders.
  • The largest Celgene Corp buyer in Q3 2019 was HBK Investments, an estimated $1.5B added.
  • The largest Celgene Corp seller in Q3 2019 was Fidelity Investments, an estimated $377M sold.

Based on aggregated 13F filings for Q3 2019.